PortageBiotech works in the drug development process and offers advice to guide novel immunotherapy assets and asset combinations from bench through human prood of concept. We reduce the risks associated with early clinical development through the use of more efficient capital manangement and scientific oversight. Our portfolio consists of 5 diverse drug platforms, with 10 products currently in preclinical or clinical development.
